Literature DB >> 11825048

The Nottingham Staphylococcus aureus population study: prevalence of MRSA among the elderly in a university hospital.

S Hori1, R Sunley, A Tami, H Grundmann.   

Abstract

A prevalence survey of methicillin-resistant Staphylococcus aureus (MRSA) in elderly patients (65 years and older) three weeks after admission to a university hospital was performed. Risk factors associated with hospital MRSA carriage were determined. The design was a cross-sectional patient-based study and all adult wards at the University Hospital Nottingham (1600 beds) were included. Three hundred and forty-two elderly individuals (65 years and older) were enrolled into the study on day 21 after admission. One hundred and twenty patients [35.08% (95% confidence intervals 29.93-40.25%)] carried S. aureus. MRSA was isolated from 54 patients. The MRSA prevalence was 158/1000 (95% CI 119-197/1000 patients). Independent risk factors for MRSA carriage in the hospital were exposure to ampicillin [adjusted odds ratio 4.1 (95% CI 1.28-13.14)] and ciprofloxacin [17.1 (95% CI 2.91-99.90)]. Forty-one MRSA isolates (75.9%) belonged to the epidemic type EMRSA 15, seven isolates to EMRSA 16 (12.9%) and six isolates were sporadic strains as determined by genetic typing. It can be expected that among this defined risk group, between 187 and 331 patients carried MRSA on discharge in the year 2000. MRSA carriage is frequent and detected in only 15% of actual carriers amongst elderly patients by routine clinical investigations three weeks after admission. The only significant risk factor identified by multivariate logistic regression was antibiotic chemotherapy. The repeated finding of a strong association between MRSA colonization and previous ciprofloxacin exposure demands attention and indicates that fluoroquinolones should be used prudently in institutions where MRSA is endemic. Copyright 2001 The Hospital Infection Society.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11825048     DOI: 10.1053/jhin.2001.1130

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  11 in total

1.  Nottingham Staphylococcus aureus population study: prevalence of MRSA among elderly people in the community.

Authors:  Hajo Grundmann; Adriana Tami; Satoshi Hori; Muhammad Halwani; Richard Slack
Journal:  BMJ       Date:  2002-06-08

2.  MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003.

Authors:  David H Wyllie; Tim E A Peto; Derrick Crook
Journal:  BMJ       Date:  2005-09-09

3.  Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing.

Authors:  M C J Bootsma; O Diekmann; M J M Bonten
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-24       Impact factor: 11.205

4.  Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections.

Authors:  Jill M Butterfield; Brian T Tsuji; Jack Brown; Elizabeth Dodds Ashley; Dwight Hardy; Kristen Brown; Alan Forrest; Thomas P Lodise
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

5.  Cost-savings achieved by eradication of epidemic methicillin-resistant Staphylococcus aureus (EMRSA)-16 from a large teaching hospital.

Authors:  I Björholt; E Haglind
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-08-18       Impact factor: 3.267

6.  Financial implications of plans to combat methicillin-resistant Staphylococcus aureus (MRSA) in an orthopaedic department.

Authors:  K Hassan; C Koh; D Karunaratne; C Hughes; S N Giles
Journal:  Ann R Coll Surg Engl       Date:  2007-10       Impact factor: 1.891

7.  A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic.

Authors:  Matthew T G Holden; Li-Yang Hsu; Kevin Kurt; Lucy A Weinert; Alison E Mather; Simon R Harris; Birgit Strommenger; Franziska Layer; Wolfgang Witte; Herminia de Lencastre; Robert Skov; Henrik Westh; Helena Zemlicková; Geoffrey Coombs; Angela M Kearns; Robert L R Hill; Jonathan Edgeworth; Ian Gould; Vanya Gant; Jonathan Cooke; Giles F Edwards; Paul R McAdam; Kate E Templeton; Angela McCann; Zhemin Zhou; Santiago Castillo-Ramírez; Edward J Feil; Lyndsey O Hudson; Mark C Enright; Francois Balloux; David M Aanensen; Brian G Spratt; J Ross Fitzgerald; Julian Parkhill; Mark Achtman; Stephen D Bentley; Ulrich Nübel
Journal:  Genome Res       Date:  2013-01-08       Impact factor: 9.043

8.  Modelling the costs and effects of selective and universal hospital admission screening for methicillin-resistant Staphylococcus aureus.

Authors:  Gijs Hubben; Martin Bootsma; Michiel Luteijn; Diarmuid Glynn; David Bishai; Marc Bonten; Maarten Postma
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

Review 9.  MRSA prevalence in European healthcare settings: a review.

Authors:  Madeleine Dulon; Frank Haamann; Claudia Peters; Anja Schablon; Albert Nienhaus
Journal:  BMC Infect Dis       Date:  2011-05-20       Impact factor: 3.090

10.  Prevalence of antimicrobial-resistant bacteria isolated from older versus younger hospitalized adults: results of a two-centre study.

Authors:  Stephen G Weber; Ram R Miller; Eli N Perencevich; Jocelyn Tolentino; David Meltzer; David Pitrak; Jessina C McGregor; Greg A Sachs; Anthony D Harris; Jon P Furuno
Journal:  J Antimicrob Chemother       Date:  2009-09-24       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.